These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31744096)
1. Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis? Schwenkenbecher P; Konen FF; Wurster U; Witte T; Gingele S; Sühs KW; Stangel M; Skripuletz T Diagnostics (Basel); 2019 Nov; 9(4):. PubMed ID: 31744096 [TBL] [Abstract][Full Text] [Related]
2. Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases. Konen FF; Schwenkenbecher P; Jendretzky KF; Gingele S; Witte T; Sühs KW; Grothe M; Hannich MJ; Süße M; Skripuletz T Brain Sci; 2022 Apr; 12(4):. PubMed ID: 35448006 [TBL] [Abstract][Full Text] [Related]
3. The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid. Konen FF; Schwenkenbecher P; Wurster U; Jendretzky KF; Möhn N; Gingele S; Sühs KW; Hannich MJ; Grothe M; Witte T; Stangel M; Süße M; Skripuletz T J Cent Nerv Syst Dis; 2021; 13():11795735211042166. PubMed ID: 34840504 [TBL] [Abstract][Full Text] [Related]
4. The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis. Konen FF; Schwenkenbecher P; Jendretzky KF; Gingele S; Sühs KW; Tumani H; Süße M; Skripuletz T Cells; 2021 Nov; 10(11):. PubMed ID: 34831279 [TBL] [Abstract][Full Text] [Related]
5. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset. Vasilj M; Kes VB; Vrkic N; Vukasovic I Clin Neurol Neurosurg; 2018 Nov; 174():220-229. PubMed ID: 30278299 [TBL] [Abstract][Full Text] [Related]
6. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort. Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H Front Immunol; 2019; 10():641. PubMed ID: 30984199 [No Abstract] [Full Text] [Related]
7. Kappa Free Light Chains in Cerebrospinal Fluid of Patients with Identified Oligoclonal Immunoglobulin G. Vasilj M; Klarić M; Vrkić N; Mikulić I; Boras MM; Jelić-Knezović N; Šoljić V Psychiatr Danub; 2017 May; 29(Suppl 2):124-128. PubMed ID: 28492219 [TBL] [Abstract][Full Text] [Related]
8. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study. Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348 [TBL] [Abstract][Full Text] [Related]
9. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis. Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis. Senel M; Tumani H; Lauda F; Presslauer S; Mojib-Yezdani R; Otto M; Brettschneider J PLoS One; 2014; 9(4):e88680. PubMed ID: 24695382 [TBL] [Abstract][Full Text] [Related]